Fascin immunoreactivity correlates with tumor grade in non-small cell lung cancer (NSCLC).

被引:0
|
作者
del Rosario, A [1 ]
Goncharuk, VN [1 ]
Tran, TA [1 ]
Sheehan, CE [1 ]
Ross, JS [1 ]
机构
[1] Albany Med Coll, Albany, NY 12208 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1283
引用
收藏
页码:218A / 218A
页数:1
相关论文
共 50 条
  • [1] Fascin immunoreactivity correlates with tumor grade in non-small cell lung cancer (NSCLC).
    del Rosario, A
    Goncharuk, VN
    Tran, TA
    Sheehan, CE
    Ross, JS
    MODERN PATHOLOGY, 2001, 14 (01) : 218A - 218A
  • [2] Fascin immunoreactivity correlates with invasive growth phenotype and poor prognosis in stage I non-small cell lung cancer (NSCLC)
    Pelosi, G
    Pasini, F
    Iannucci, A
    Sonzogni, A
    Viale, G
    LABORATORY INVESTIGATION, 2002, 82 (01) : 326A - 326A
  • [3] Fascia immunoreactivity correlates with invasive growth phenotype and poor prognosis in stage I non-small cell lung cancer (NSCLC)
    Pelosi, G
    Pasini, F
    Iannucci, A
    Sonzogni, A
    Viale, G
    MODERN PATHOLOGY, 2002, 15 (01) : 326A - 326A
  • [4] The generation of tumor reactive lymphocytes in non-small cell lung cancer (NSCLC)
    Yannelli, JR
    Wroblewski, JM
    FASEB JOURNAL, 2002, 16 (04): : A667 - A667
  • [5] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [6] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [7] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [8] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [9] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [10] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42